Drugs Made In America Acquisition Corp. - Rights

Share · KYG2847J1123 · DMAAR (XNAS)

No Price

27.01.2026 14:30

Current Prices from Drugs Made In America Acquisition Corp. - Rights

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	DMAAR	USD	27.01.2026 14:30	0,14 USD	-0,0001 USD -0,07 %

Share Float & Liquidity

Free Float 86,31 %

Shares Float 17,61 M

Shares Outstanding 20,4 M

Company Profile for Drugs Made In America Acquisition Corp. - Rights Share

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

AI Analysis of Drugs Made In America Acquisition Corp. - Rights

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Drugs Made In America Acquisition Corp. - Rights

No AI threads available for this company yet.

Company Data

Name Drugs Made In America Acquisition Corp. - Rights

Company Drugs Made In America Acquisition Corp. Rights

Symbol DMAAR

Website https://dmaacorp.com

Primary Exchange

NASDAQ

ISIN KYG2847J1123

Asset Class Share

Sector Financial Services

Industry Shell Companies

CEO Lynn Stockwell

Country United States of America

Currency USD

Employees -

Address 1 East Broward Blvd Suite 700, 33301 Fort Lauderdale

Ticker Symbols

Name	Symbol
NASDAQ	DMAAR

More Shares

Investors who hold Drugs Made In America Acquisition Corp. - Rights also have the following shares in their portfolio:

iShares Gold Trust Micro Shares ETF

LLOYDS BANK PLC CALL ZRO CPN NTS 21/07/46 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog